Zusammenfassung
Die Neurofibromatosen zählen zu den vererbbaren neurokutanen Syndromen, den Phakomatosen, zu deren Gruppe neben der Neurofibromatose Typ 1 (NF1) und Typ 2 (NF2) auch die Schwannomatose zählt. Als gemeinsames Merkmal weisen sie eine Prädisposition zur Entwicklung von Tumoren, die von den Schwann-Zellen der Nervenscheiden ausgehen, auf. Im Hinblick auf die Genetik und das klinische Erscheinungsbild der Erkrankungen handelt es sich jedoch um unterschiedliche Entitäten, die auch im folgenden Beitrag gesondert abgehandelt werden. Neben der Darstellung der typischen klinischen Befunde und der Diagnosekriterien werden die für die jeweilige Erkrankung charakteristischen Bildbefunde demonstriert, insbesondere hinsichtlich der Rolle der bildgebenden Verfahren bei der Diagnosestellung, im Verlauf und bei der Prognoseabschätzung dieser multisystemischen Erkrankungen.
Abstract
Neurofibromatosis type 1 (NF1) and type 2 (NF2) are hereditary autosomal dominant neurocutaneous disorders, the phacomatoses, characterized by the development of tumors derived from the cells of the peripheral nerve sheath and also includes schwannomatosis. Regarding the clinical and genetic aspects they are, however, two distinct entities which are described separately in the following review. In addition to the typical clinical presentation and diagnostic criteria, characteristic imaging findings are presented especially in terms of the role of imaging in the diagnosis, follow-up and assessment of prognostic aspects in these multisystemic disorders.
Literatur
Antinheimo J, Sankila R, Carpén O et al (2000) Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningeomas and schwannomas. Neurology 54(1):71–76
Aoki S, Barkovich AJ, Nihimura K et al (1989) Neurofibromatosis type 1 & 2: cranial MR findings. Radiology 172:527–534
Baehring JM, Betensky RA, Batcherlor TT (2003) Malignant peripheral nerve sheath tumor: the clinical spectrum and outcome of treatment. Neurology 61:696–698
Baser ME, Freidman JM, Aeschliman D et al (2002) Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet 71(4):715–723
Baser ME, Friedman JM, Wallace AJ et al (2002) Evaluation of clinical diagnostic criteria of neurofibromatosis 2. Neurology 59:1759–1765
Bilaniuk LT, Malloy PT, Zimmermann RA et al (1997) Neurofibromatosis type 1: brainstem tumors. Neuroradiology 39:642–653
Deimling A, Perry A (2007) Neurofibromatosis type 1. In: Louis DN, Oghaki H, Wiestler OD, Cavenee WK (Hrsg) World Health Organization classification of tumours of the central nervous system. IARC Press, Lyon, S 205–209
DiPaolo DP, Zimmermann RA, Rorke LB et al (1995) Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology 195:721–724
Evans DGR (2009) Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 19(4):16
Evans DGR, Huson S, Donnai D et al (1992) A clinical study of type2 neurofibromatosis. Q J Med 84:603–618
Evans DGR, Huson SM, Donnai D et al (1992) A genetic study of type 2 neurofibromatosis in the United Kingdom 1: prevalence, mutation rate, fitness and confirmation of maternal transmission effect on severity. J Med Genet 29:841–846
Evans DGR, Ramsden R, Birch J (1999) Pediatric presentation of type 2 neurofibromatosis. Arch Dis Child 81:496–499
Evans DGR, Ramsden R, Huson SM et al (1993) Type 2 neurofibromatosis: the need of supraregional care? J Laryngol Otol 107:401–406
Ferner RE, Chaudhuri R, Bingham J et al (1993) The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 56:492–495
Ferner RE, Gutmann DH (2002) International Consensus Statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62:1573–1577
Hottinger AF, Khakoo Y (2009) Neurooncology of neurofibromatosis type 1. Curr Treat Options Neurol 11:306–314
King A, Biggs N, Ramsden RT et al (2005) Spinal tumors in neurofibromatosis type 2: is emerging knowledge of genotype predictive of natural history? J Neurosurg Spine 2(5):574–579
Levisohn PM, Mikhael MA, Rothman SM (1978) Cerebrovascular changes in neurofibromatosis. Dev Med Child Neurol 20:789–793
Listernick R, Charrow J, Greenwald MJ et al (1989) Optic gliomas in children with neurofibromatosis type 1. J Pediatr 114:788–792
Mautner VF, Lindenau M, Baser ME et al (1996) The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 38:880–885
o A (o J) National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Arch Neurol 45:575–578
Parry DM, Eldridge R, Kaiser-Kupfer MI et al (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogenitiy. Am J Med Genet 52:450–451
Patil S, Chamberlain RS (2012) Neoplasms associated with germline and somatic NF1 gene mutations. Oncologist 17:101–116
Patronas NJ, Courcoutsakis N, Bromley CM et al (2001) Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype. Radiology 218(2):434–442
Rainov NG, Heidecke V, Burkert W (1995) Thoracic and lumbar meningocele in neurofibromatosis type 1: report oft wo cases and review of the literature. Neurosurg Rev 18:127–134
Rosser T, Packer RJ (2002) intracranial neoplasms in children with neurofibromatosis 1. J Child Neurol 17:630–636
Rouleau GA, Merel P, Lutchman M et al (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363:515–521
Sorensen SA, Mulvihill JJ, Nielsen A (1986) Long-term follow-up of von Recklinghausen neurofibromatosis: survival and malignant neoplasms. N Engl J Med 314:1010–1015
Troffater JA, MacCollin MM, Rutter JL, Murrell JR et al (1993) A novel moezin-, ezrin-radixin-like gene is a candidatefor the neurofibromatosis 2 tumor suppressor. Cell 72:791–800
Einhaltung ethischer Richtlinien
Interessenkonflikt. A. Zimmer gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zimmer, A. Neurofibromatosen. Radiologe 53, 1077–1083 (2013). https://doi.org/10.1007/s00117-013-2555-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-013-2555-9